Carl Dambkowski, Chief Medical Officer at Apogee Therapeutics, Inc. (APGE), sold 13,330 shares at $58.91 ($788K) on 2024-11-06, disclosed to the SEC on 2024-11-08.
Scheduled sale ($788k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $58.91 | 5,326 | $314K | 39.8% |
| 2 | $58.91 | 5,326 | $314K | 39.8% |
| 3 | $59.96 | 1,339 | $80K | 10.2% |
| 4 | $59.96 | 1,339 | $80K | 10.2% |
| Total | $59.12 avg | 13,330 | $788K | 100% |
| Filing → |
| ORKA | SELL | 2026-06-12 | $2.5M | — | Filing → |
| APGE | SELL | 2026-06-05 | $433K | — | Filing → |
| ORKA | SELL | 2026-05-22 | $6.2M | — | Filing → |